Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric S Christenson

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Breast Cancer Research and Treatment|December 19, 2018
The estrogen receptor-alpha S118P variant does not affect breast cancer incidence or response to endocrine therapiesBerry Button, Sarah Croessmann, David Chu, et al.
JCO Precision Oncology|July 14, 2018
Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor BoardW Brian Dalton, Patrick M Forde, Hyunseok Kang, et al.
Nature Communications|June 23, 2026
Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trialHejia Henry Wang, Amanda L Huff, S Daniel Haldar, et al.
Oncotarget|January 30, 2016
Ki-67 is required for maintenance of cancer stem cells but not cell proliferationJustin Cidado, Hong Yuen Wong, D Marc Rosen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2025
Nivolumab and Relatlimab for the treatment of patients with unresectable or metastatic mismatch repair proficient colorectal cancerEric S Christenson, Won Jin Ho, Daniel Shu, et al.
The Journal of Clinical Investigation|August 9, 2019
Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivationW Brian Dalton, Eric Helmenstine, Noel Walsh, et al.
Iscience|January 15, 2025
CD137 agonism enhances anti-PD1 induced activation of expanded CD8<sup>+</sup> T cell clones in a neoadjuvant pancreatic cancer clinical trialJanelle M Montagne, Jacob T Mitchell, Joseph A Tandurella, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Breast Cancer Research and Treatment|December 19, 2018
The estrogen receptor-alpha S118P variant does not affect breast cancer incidence or response to endocrine therapiesBerry Button, Sarah Croessmann, David Chu, et al.
JCO Precision Oncology|July 14, 2018
Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor BoardW Brian Dalton, Patrick M Forde, Hyunseok Kang, et al.
Nature Communications|June 23, 2026
Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trialHejia Henry Wang, Amanda L Huff, S Daniel Haldar, et al.
Oncotarget|January 30, 2016
Ki-67 is required for maintenance of cancer stem cells but not cell proliferationJustin Cidado, Hong Yuen Wong, D Marc Rosen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2025
Nivolumab and Relatlimab for the treatment of patients with unresectable or metastatic mismatch repair proficient colorectal cancerEric S Christenson, Won Jin Ho, Daniel Shu, et al.
The Journal of Clinical Investigation|August 9, 2019
Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivationW Brian Dalton, Eric Helmenstine, Noel Walsh, et al.
Iscience|January 15, 2025
CD137 agonism enhances anti-PD1 induced activation of expanded CD8<sup>+</sup> T cell clones in a neoadjuvant pancreatic cancer clinical trialJanelle M Montagne, Jacob T Mitchell, Joseph A Tandurella, et al.
Pageof 4